Tranexamic acid is beneficial for blood management of high tibial osteotomy: a randomized controlled study

Introduction The purpose of this study was to investigate whether TXA can effectively reduce blood loss after HTO and related complications and to evaluate its safety. Materials and methods From March 2016 to March 2018, 100 patients who underwent medial opening wedge HTO in the Department of Orthopedics, the second affiliated hospital of xi'an jiaotong university, with an average age of 52.8 +/- 3.2 years, were randomly divided into the TXA group (using intravenous TXA) and the control group (using the same amount of normal saline), with 50 patients in each group. The postoperative wound drainage volume, decrease in hemoglobin and hematocrit value, total blood loss, wound healing, blood transfusion, deep venous thrombosis (DVT) and pulmonary embolism (PE) were compared between the two groups. Results The drainage volume on the first postoperative day and the total drainage volume of the TXA group were significantly lower compared with those of the control group (145.7 vs 264.5 ml, 282.3 vs 413.2 ml,P < 0.05). The decreases in the hemoglobin and hematocrit values on the postoperative first, second and fifth days were lower in the TXA group than those in the control group (1.4VS3.5, 2.6 vs 3.3, 1.9 vs 2.9 g,P < 0.05; 3.3 vs 5.5, 5.0 vs 9.1, 3.8 vs 7.2%,P < 0.05), and the mean total blood loss was also lower in the TXA group than that in the control group (477.9 vs 834.6 ml,P < 0.05). In the control group, 1 patient had wound hematoma requiring additional paracentesis and pressure dressing, 1 patient had superficial wound infection requiring additional debridement, and 1 patient had postoperative blood transfusion compared to none in the TXA group (P > 0.05). There was no symptomatic DVT or PE in either of the groups. Conclusion Intravenous TXA can effectively and safely reduce blood loss and bleeding-related complications after HTO and was beneficial for the blood management of HTO.

Automated summary

The study investigated the effectiveness and safety of TXA in reducing blood loss and complications after HTO. Results showed that TXA significantly reduced drainage volume, hemoglobin and hematocrit decrease, and total blood loss compared to the control group, with fewer postoperative complications in the TXA group. Overall, intravenous TXA was found to be beneficial for blood management in HTO procedures.